Logo image of CMCOM.AS

CM.COM (CMCOM.AS) Stock Fundamental Analysis

AMS:CMCOM - NL0012747059 - Common Stock

4.62 EUR
-0.02 (-0.54%)
Last: 9/2/2025, 5:29:45 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CMCOM. CMCOM was compared to 108 industry peers in the Software industry. Both the profitability and financial health of CMCOM have multiple concerns. CMCOM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CMCOM has reported negative net income.
In the past year CMCOM had a positive cash flow from operations.
In the past 5 years CMCOM always reported negative net income.
In multiple years CMCOM reported negative operating cash flow during the last 5 years.
CMCOM.AS Yearly Net Income VS EBIT VS OCF VS FCFCMCOM.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

CMCOM's Return On Assets of -5.51% is on the low side compared to the rest of the industry. CMCOM is outperformed by 66.67% of its industry peers.
With a Return On Equity value of -43.39%, CMCOM is not doing good in the industry: 76.85% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -5.51%
ROE -43.39%
ROIC N/A
ROA(3y)-12.09%
ROA(5y)-10.1%
ROE(3y)-160.78%
ROE(5y)-102.61%
ROIC(3y)N/A
ROIC(5y)N/A
CMCOM.AS Yearly ROA, ROE, ROICCMCOM.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

Looking at the Gross Margin, with a value of 31.46%, CMCOM is doing worse than 78.70% of the companies in the same industry.
CMCOM's Gross Margin has improved in the last couple of years.
CMCOM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.67%
GM growth 5YN/A
CMCOM.AS Yearly Profit, Operating, Gross MarginsCMCOM.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

CMCOM does not have a ROIC to compare to the WACC, probably because it is not profitable.
CMCOM has about the same amout of shares outstanding than it did 1 year ago.
CMCOM has more shares outstanding than it did 5 years ago.
CMCOM has a worse debt/assets ratio than last year.
CMCOM.AS Yearly Shares OutstandingCMCOM.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CMCOM.AS Yearly Total Debt VS Total AssetsCMCOM.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.76, we must say that CMCOM is in the distress zone and has some risk of bankruptcy.
CMCOM has a Altman-Z score of 0.76. This is in the lower half of the industry: CMCOM underperforms 76.85% of its industry peers.
The Debt to FCF ratio of CMCOM is 8.53, which is on the high side as it means it would take CMCOM, 8.53 years of fcf income to pay off all of its debts.
CMCOM's Debt to FCF ratio of 8.53 is in line compared to the rest of the industry. CMCOM outperforms 47.22% of its industry peers.
A Debt/Equity ratio of 2.99 is on the high side and indicates that CMCOM has dependencies on debt financing.
CMCOM has a worse Debt to Equity ratio (2.99) than 81.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 8.53
Altman-Z 0.76
ROIC/WACCN/A
WACC6.92%
CMCOM.AS Yearly LT Debt VS Equity VS FCFCMCOM.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

CMCOM has a Current Ratio of 0.86. This is a bad value and indicates that CMCOM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.86, CMCOM is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
A Quick Ratio of 0.86 indicates that CMCOM may have some problems paying its short term obligations.
CMCOM's Quick ratio of 0.86 is on the low side compared to the rest of the industry. CMCOM is outperformed by 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.86
CMCOM.AS Yearly Current Assets VS Current LiabilitesCMCOM.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

CMCOM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.13%, which is quite impressive.
The Revenue has been growing slightly by 0.36% in the past year.
CMCOM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.98% yearly.
EPS 1Y (TTM)35.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.89%
Revenue 1Y (TTM)0.36%
Revenue growth 3Y4.98%
Revenue growth 5YN/A
Sales Q2Q%-7.46%

3.2 Future

CMCOM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.05% yearly.
Based on estimates for the next years, CMCOM will show a small growth in Revenue. The Revenue will grow by 7.99% on average per year.
EPS Next Y50.66%
EPS Next 2Y37.17%
EPS Next 3Y33.05%
EPS Next 5YN/A
Revenue Next Year-2.56%
Revenue Next 2Y0.97%
Revenue Next 3Y2.58%
Revenue Next 5Y7.99%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMCOM.AS Yearly Revenue VS EstimatesCMCOM.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
CMCOM.AS Yearly EPS VS EstimatesCMCOM.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CMCOM. In the last year negative earnings were reported.
Also next year CMCOM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CMCOM.AS Price Earnings VS Forward Price EarningsCMCOM.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMCOM indicates a rather cheap valuation: CMCOM is cheaper than 93.52% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CMCOM is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.23
EV/EBITDA 6.81
CMCOM.AS Per share dataCMCOM.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

CMCOM's earnings are expected to grow with 33.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.17%
EPS Next 3Y33.05%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CMCOM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CM.COM

AMS:CMCOM (9/2/2025, 5:29:45 PM)

4.62

-0.02 (-0.54%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-23 2025-07-23
Earnings (Next)10-21 2025-10-21
Inst Owners4.91%
Inst Owner ChangeN/A
Ins Owners45.8%
Ins Owner ChangeN/A
Market Cap148.53M
Analysts80
Price Target6.66 (44.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-23.74%
PT rev (3m)-19.34%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-108.33%
EPS NY rev (3m)-108.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-8.69%
Revenue NY rev (3m)-12.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.56
P/FCF 15.23
P/OCF 5.73
P/B 5.52
P/tB N/A
EV/EBITDA 6.81
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)0.3
FCFY6.56%
OCF(TTM)0.81
OCFY17.44%
SpS8.22
BVpS0.84
TBVpS-1.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.51%
ROE -43.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.46%
FCFM 3.69%
ROA(3y)-12.09%
ROA(5y)-10.1%
ROE(3y)-160.78%
ROE(5y)-102.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.67%
GM growth 5YN/A
F-Score6
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 8.53
Debt/EBITDA 2.79
Cap/Depr 50.6%
Cap/Sales 6.12%
Interest Coverage N/A
Cash Conversion 89.86%
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.86
Altman-Z 0.76
F-Score6
WACC6.92%
ROIC/WACCN/A
Cap/Depr(3y)82.13%
Cap/Depr(5y)88.9%
Cap/Sales(3y)6.71%
Cap/Sales(5y)6.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.89%
EPS Next Y50.66%
EPS Next 2Y37.17%
EPS Next 3Y33.05%
EPS Next 5YN/A
Revenue 1Y (TTM)0.36%
Revenue growth 3Y4.98%
Revenue growth 5YN/A
Sales Q2Q%-7.46%
Revenue Next Year-2.56%
Revenue Next 2Y0.97%
Revenue Next 3Y2.58%
Revenue Next 5Y7.99%
EBIT growth 1Y75.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7900.08%
EBIT Next 3Y405.93%
EBIT Next 5Y234.68%
FCF growth 1Y140.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1301.25%
OCF growth 3Y84.76%
OCF growth 5YN/A